|
By Susan Okie
More Americans are taking anti-anxiety
drugs in the wake of the Sept. 11 terrorist attacks, and new
prescriptions for such medications have increased sharply
in the New York and Washington areas.
Combined with recent national surveys
and interviews with psychiatrists in this area and elsewhere,
the latest data on prescription drugs support a picture of
a nation recovering but
still emotionally fragile after the attacks, which
killed more than 5,000 people, triggered unprecedented security
measures nationwide and launched a worldwide war on terrorism.
No national figures are available on how
many Americans are being treated for anxiety, depression or
other mental symptoms in the wake of the attacks. However,
data on prescription drugs commonly used for such symptoms
provide an indirect measure indicating the level of anxiety
among Americans.
Selma Wade, 68, suffered a heart attack
on Sept. 11, a few hours after learning of the terrorist attacks.
Since then, while recovering from surgery at Washington Hospital
Center, "I've been afraid to sleep in this hospital bed,"
she said.
"I haven't had nightmares about
bombs. It's been more about troubles, confusion, anxiety,
being worried about who's safe and who's not safe."
NDCHealth, a private company that provides
information to the health care industry, compiled data on
selected prescription drugs for The Washington Post.
The figures for several commonly used
anti-anxiety drugs remained fairly constant during the past
year, then showed a sudden
jump in the weeks after the attacks.
For example, the number of new prescriptions
filled for alprazolam (the generic version of Xanax) was 22
percent greater in New York and 12 percent greater in Washington
during the week ending Sept. 28, compared with a year earlier.
Nationally, it was 9 percent greater.
For lorazepam (the generic version of
Ativan), prescriptions during the same week were up 19 percent
in New York and 16 percent in Washington compared with a year
earlier. Nationally, they were up 6.3 percent.
For diazepam (the generic version of Valium,
an older anti-anxiety drug), the number of new prescriptions
during the same week was 14
percent greater in Washington and 8 percent greater in New
York, compared with the same week a year earlier.
Nationally, the increase was 3 percent.
In contrast to the anti-anxiety drugs,
Ambien, the most widely prescribed sleeping pill on the list,
has shown a fairly steady rise in prescriptions over the past
year, so it is difficult to judge whether the attacks contributed
to recent increases.
The number filled during the week ending
Sept. 28 was 20 percent greater than a year earlier. In New
York, it was 23 percent greater and in Washington, 29 percent
greater. A spokeswoman for Pharmacia Corp., the manufacturer,
declined to comment on the findings.
Several psychiatrists said they were not
surprised by the increases, noting that primary care physicians
are probably writing most of the prescriptions. They cautioned
that medications should not be the first choice of doctors
treating people distressed by the attacks and other recent
events.
"No competent psychiatrist would
approach this as an anxiety that just needs to be medicated
out of existence," said Michael Garrett, deputy director
of psychiatry at Bellevue Hospital Center in New York. "I
think the first thing one should do is talk about it.
But it's a matter of degree. There are
some people who have a marginal capacity to sleep to begin
with, and this pushes them over the edge. Giving them a decent
night's sleep with some medication is exactly what needs to
be done."
Seeing the
attacks on television triggered severe anxiety and depression
in some people who had a history
of hospitalization for mental illness, said Stephen Peterson,
chairman of the psychiatry department at Washington Hospital
Center.
Washington
Post October 14, 2001; Page A08
|